1. What the Sherman and Clayton Antitrust Acts Require
The Sherman and Clayton antitrust acts address different forms of competitive harm, so corporate risk depends on the conduct and applicable legal standard. Federal antitrust law distinguishes concerted restraints, unilateral monopolization, and transactions that may substantially lessen competition.
| Law | Primary Conduct | Core Legal Standard | Corporate Defense Focus |
|---|---|---|---|
| Sherman Act § 1 | Agreements among separate economic actors | Unreasonable restraint of interstate or foreign trade | Existence of agreement, per se versus rule-of-reason treatment |
| Sherman Act § 2 | Monopolization and attempted monopolization | Monopoly power plus exclusionary conduct; additional elements govern attempt claims | Relevant market, market power, competitive justification |
| Clayton Act § 7 | Mergers and acquisitions | Effect may substantially lessen competition or tend to create a monopoly | Market definition, competitive effects, entry, efficiencies |
| New York Donnelly Act | Restraints and monopolistic arrangements affecting New York commerce | Independent New York statutory prohibition | State nexus, challenged arrangement, parallel federal exposure |
Sherman Act § 1
- Primary ConductAgreements among separate economic actors
- Core Legal StandardUnreasonable restraint of interstate or foreign trade
- Corporate Defense FocusExistence of agreement, per se versus rule-of-reason treatment
Sherman Act § 2
- Primary ConductMonopolization and attempted monopolization
- Core Legal StandardMonopoly power plus exclusionary conduct; additional elements govern attempt claims
- Corporate Defense FocusRelevant market, market power, competitive justification
Clayton Act § 7
- Primary ConductMergers and acquisitions
- Core Legal StandardEffect may substantially lessen competition or tend to create a monopoly
- Corporate Defense FocusMarket definition, competitive effects, entry, efficiencies
New York Donnelly Act
- Primary ConductRestraints and monopolistic arrangements affecting New York commerce
- Core Legal StandardIndependent New York statutory prohibition
- Corporate Defense FocusState nexus, challenged arrangement, parallel federal exposure
Sherman Act Section 1: Agreements and Cartel Risk
Section 1 requires concerted action; lawful independent behavior does not become unlawful merely because competitors make similar commercial decisions. Naked horizontal price fixing, bid rigging, and market allocation can receive per se treatment, while many other restraints require fuller competitive-effects analysis.
For corporate counsel, the first factual question is often whether evidence actually supports an agreement. Competitor emails, trade-association communications, pricing discussions, bid records, messaging applications, and information exchanges can become central evidence.
Sherman Act Section 2: Monopolization
Section 2 does not prohibit a company from becoming large or successful through legitimate competition; monopolization requires monopoly power and exclusionary conduct.
Defense analysis commonly tests product and geographic market definition, substitution, entry barriers, market share, business justification, and the competitive effect of the challenged practice. Exclusive arrangements, pricing practices, platform restrictions, and refusals to deal require conduct-specific analysis rather than an assumption that market leadership itself creates liability.
Clayton Act Section 7: Merger and Acquisition Risk
Section 7 is prospective: regulators need not wait for competitive harm to occur before challenging an acquisition that satisfies the statutory standard.
This distinction matters during M&A planning. Hart-Scott-Rodino compliance addresses whether advance notification is required, while Section 7 addresses whether the transaction itself may substantially lessen competition. An expired HSR waiting period does not immunize a transaction from a later substantive challenge.
How Cor
2. How Corporate Antitrust Litigation Defense Starts
Antitrust litigation defense should test agreement, market definition, antitrust injury, causation, damages, and standing before document-intensive discovery expands the dispute.
Companies facing private or government litigation should coordinate pleadings, preservation, economic analysis, and regulatory communications through a single factual record. Dedicated antitrust litigation strategy is especially important when civil claims overlap with an investigation or transaction review.
Pleading Standards and Evidence of Agreement
A Sherman Act § 1 complaint must allege facts that plausibly suggest an agreement; parallel commercial conduct and a bare conspiracy allegation are insufficient alone.
The Supreme Court's decision in Bell Atlantic Corp. .. Twombly makes this distinction especially relevant at the motion-to-dismiss stage. For corporate defendants, contemporaneous documents showing independent pricing, procurement, capacity, or strategic decisions may also become important as the factual record develops.
Private federal plaintiffs who establish qualifying antitrust injury may seek treble damages and attorneys' fees under Clayton Act § 4. Federal damages actions governed by 15 U.S.C. § 15b generally must commence within four years after accrual, subject to doctrines and statutory provisions that can affect the calculation.
Government Investigations and Criminal Exposure
Potential cartel evidence requires immediate preservation and privileged legal assessment because criminal, civil, and follow-on private exposure can develop from the same conduct.
DOJ's Antitrust Division handles federal criminal antitrust prosecution, with its criminal program centered on qualifying cartel conduct such as price fixing, bid rigging, and market allocation. Companies confronting that risk may need a separate criminal antitrust assessment before employees make substantive representations to investigators.
DOJ's Corporate Leniency Policy can protect qualifying applicants, but leniency is not automatic simply because a company reports first. Eligibility turns on the policy's requirements, including the timing and circumstances of disclosure, cooperation, remediation, and other applicable conditions.
3. New York Donnelly Act and Forum Strategy
New York corporations may face Donnelly Act exposure in addition to federal claims when challenged conduct sufficiently affects business, trade, commerce, or services in New York.
General Business Law § 340 supplies New York's principal antitrust prohibition. The New York Attorney General may investigate suspected violations under GBL § 343 using subpoenas and other investigative demands, while CPLR 2304 provides a procedural mechanism for seeking appropriate relief from a subpoena.
Federal and New York Court Considerations
Federal antitrust claims and New York state claims require separate jurisdiction and venue analysis even when they arise from the same commercial conduct.
Federal cases connected to New York may proceed in the Southern District of New York or Eastern District of New York when jurisdiction and venue requirements are satisfied. Donnelly Act and related commercial claims may proceed in New York State Supreme Court.
Commercial Division assignment is not automatic. In New York County, the monetary threshold is generally $500,000, subject to the governing rule and specified exceptions; the dispute must also fall within the Division's commercial subject-matter requirements.
4. 2026 HSR Merger Review and Clayton Act Compliance
Corporate transaction teams should analyze HSR reportability and substantive Clayton Act risk separately before signing, filing, or closing a competitively sensitive deal.
For 2026, the basic HSR size-of-transaction threshold is $133.9 million, effective February 17, 2026. Reportability still depends on the complete statutory analysis, including applicable size-of-person tests, exemptions, aggregation rules, transaction structure, and beneficial ownership.
Current HSR Filing Procedure
As of September 2026, transaction teams should confirm the operative HSR form immediately before filing because the filing framework changed during 2026 litigation.
The FTC states that, after a federal court vacated the form that became effective in February 2025 and an appellate court declined to stay that ruling, the agencies accept the pre-February 10, 2025 form. The agencies also state that they voluntarily accept the updated form. This procedural position can change through further litigation or agency action.
Deal documents deserve particular attention. Board materials, valuation presentations, banker decks, and executive communications describing a transaction as eliminating a competitor, controlling capacity, preventing entry, or increasing pricing power may become significant evidence in a merger investigation.
5. Building a Federal Antitrust Compliance Program
A defensible federal antitrust compliance program should address the company's actual competitor contacts, pricing systems, transactions, sales channels, procurement practices, and information flows.
Generic annual training is rarely enough for a business with material competition risk. A tailored antitrust compliance framework should connect written rules to the employees and business processes most likely to generate exposure.
Controls for Higher-Risk Business Functions
Higher-risk employees need practical rules governing what they may discuss, exchange, approve, and document when dealing with competitors or competitively sensitive information.
A corporate program should consider:
- Role-specific controls for sales, procurement, recruiting, M&A, and business-development personnel.
- Protocols for trade associations, benchmarking, joint ventures, and competitor meetings.
- Review procedures for pricing algorithms, competitively sensitive data exchanges, and third-party information platforms.
- Reporting channels that permit prompt escalation of suspected antitrust conduct.
- Preservation rules covering email, personal devices used for business, collaboration tools, and ephemeral messaging.
- Periodic testing and remediation tied to identified business risks rather than policy acknowledgments alone.
DOJ's current criminal antitrust compliance guidance evaluates whether a program is appropriately designed, applied in good faith, supported with adequate resources, monitored, and improved when misconduct or control failures emerge.
6. Ractical Pitfalls for Corporate Legal Teams
Corporate antitrust exposure often worsens because of procedural and evidentiary mistakes made after a company first identifies a potential competition issue.
Common pitfalls include:
- Assuming parallel pricing proves collusion, or assuming the absence of a written agreement eliminates Section 1 risk.
- Allowing routine deletion practices to continue after litigation, a subpoena, or another preservation trigger arises.
- Treating HSR clearance or expiration of the waiting period as substantive approval under Clayton Act § 7.
- Interviewing key employees before establishing privilege, document preservation, and a consistent investigation protocol.
- Permitting business teams to create speculative market-share or competitor-elimination narratives during an active transaction.
- Responding independently to DOJ, FTC, New York Attorney General, and private litigation without coordinating factual positions.
- Using a generic compliance policy that does not address the company's actual competitor contacts and decision-making systems.
7. Frequently Asked Questions
Corporate antitrust decisions should begin with the statute, type of conduct, enforcement posture, and evidence rather than a generalized assessment of competitive risk.
The Sherman Act principally addresses agreements restraining trade and monopolization. The Clayton Act addresses specified practices and transactions, including mergers that may substantially lessen competition.
Yes. Federal Sherman or Clayton Act exposure can overlap with New York Donnelly Act scrutiny, and the New York Attorney General has independent investigative and enforcement authority under state law.
No. HSR establishes a premerger notification and waiting-period process for qualifying transactions. Section 7 remains a separate substantive prohibition, and consummated transactions can still face investigation or challenge.
The company should preserve potentially relevant evidence, limit unnecessary factual communications, and initiate a privileged legal assessment. Counsel should evaluate government exposure, employee issues, parallel civil risk, and any potential leniency question before substantive outreach to enforcement authorities.
01 Sep, 2026
